Cargando…
Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications
The t(8;21) abnormality occurs in a minority of acute myeloid leukemia (AML) patients. The translocation results in an in-frame fusion of two genes, resulting in a fusion protein of one N-terminal domain from the AML1 gene and four C-terminal domains from the ETO gene. This protein has multiple effe...
Autores principales: | Reikvam, Håkon, Hatfield, Kimberley Joanne, Kittang, Astrid Olsnes, Hovland, Randi, Bruserud, Øystein |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100545/ https://www.ncbi.nlm.nih.gov/pubmed/21629739 http://dx.doi.org/10.1155/2011/104631 |
Ejemplares similares
-
The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine—The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell Transplantation
por: Reikvam, Håkon, et al.
Publicado: (2013) -
Correction: Pharmacologic targeting of the PI3K/mTOR pathway controls
release of angioregulators from primary human acute myeloid leukemia cells and their
neighboring stromal cells
por: Reikvam, Håkon, et al.
Publicado: (2017) -
Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells
por: Reikvam, Håkon, et al.
Publicado: (2013) -
Clonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse Prognosis
por: Nepstad, Ina, et al.
Publicado: (2018) -
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
por: Reikvam, Håkon, et al.
Publicado: (2022)